Abstract submission is NOW OPEN through Jan. 31, 2025! Send us your research for possible presentation at the 28th Annual Meeting!
As part of ASGCT’s efforts to expand its mission outside of the U.S., we're now offering all the benefits of membership at reduced rates to individuals living in countries with low- and middle-income economies as classified by the World Bank.
Members residing in countries designated as upper-middle income economies, such as Brazil, South Africa, and many others, will be eligible for a 50 percent reduction on membership dues. Members residing in countries designated as lower middle-income economies, including Ukraine, India, and many others, will be eligible for a 75 percent reduction on membership dues. Members residing in countries designated as low-income economies will be eligible for a 90 percent reduction on membership dues.
Membership Type
Upper-Middle Income
Lower-Middle Income
Low-Income
Associate Member
$37.50
$18.75
$7.50
Transitional Member
$55
$27.50
$11
Member
$110
$22
If you have any questions, please contact info@asgct.org. Individuals who receive these reduced rates will only be eligible for the online version of ASGCT's journal, Molecular Therapy.
Become a Member
January 22-23, 2025 | Virtual
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico